Lastly, because mutant ATXN3 stabilizes P53 leading to an increased abundance of p53 in MJD cellular models [21], future quantification of the P53 protein in peripheral blood from MJD carriers could reveal a new progression biomarker for MJD. The gene discussed is TP53; the disease is Machado-Joseph disease.